OraSure Technologies Long Term Debt 2012-2025 | OSUR
OraSure Technologies long term debt from 2012 to 2025. Long term debt can be defined as the sum of all long term debt fields.
|
OraSure Technologies Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $1 |
| 2021 | $2 |
| 2020 | $1 |
| 2019 | $1 |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
| 2013 | |
| 2012 | |
| 2011 | |
|
OraSure Technologies Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2025-09-30 | $0 |
| 2025-06-30 | $0 |
| 2025-03-31 | $0 |
| 2024-12-31 | $0 |
| 2024-09-30 | $0 |
| 2024-06-30 | $0 |
| 2024-03-31 | $0 |
| 2023-12-31 | $0 |
| 2023-09-30 | $0 |
| 2023-06-30 | $0 |
| 2023-03-31 | $0 |
| 2022-12-31 | $1 |
| 2022-09-30 | $1 |
| 2022-06-30 | $1 |
| 2022-03-31 | $1 |
| 2021-12-31 | $2 |
| 2021-09-30 | $3 |
| 2021-06-30 | $2 |
| 2021-03-31 | $1 |
| 2020-12-31 | $1 |
| 2020-09-30 | $1 |
| 2020-06-30 | $1 |
| 2020-03-31 | $1 |
| 2019-12-31 | $1 |
| 2019-09-30 | $1 |
| 2019-06-30 | $1 |
| 2019-03-31 | $1 |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| 2015-03-31 | |
| 2014-12-31 | |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | |
| 2013-09-30 | |
| 2013-06-30 | |
| 2013-03-31 | |
| 2012-12-31 | |
| 2012-09-30 | |
| 2012-06-30 | |
| 2012-03-31 | |
| 2011-12-31 | |
| 2011-09-30 | |
| 2011-06-30 | |
| 2011-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.209B | $0.186B |
| OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $190.250B | 21.25 |
| EssilorLuxottica (ESLOY) | France | $141.053B | 0.00 |
| Stryker (SYK) | United States | $140.785B | 27.01 |
| Boston Scientific (BSX) | United States | $136.192B | 31.14 |
| Medtronic (MDT) | Ireland | $131.676B | 18.24 |
| Medline (MDLN) | United States | $59.144B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.791B | 0.00 |
| Agilent Technologies (A) | United States | $38.383B | 24.26 |
| ResMed (RMD) | United States | $37.110B | 24.78 |
| GE HealthCare Technologies (GEHC) | United States | $36.492B | 17.45 |
| Koninklijke Philips (PHG) | Netherlands | $27.828B | 18.18 |
| Terumo (TRUMY) | Japan | $19.515B | 22.05 |
| Insulet (PODD) | United States | $18.052B | 56.03 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.087B | 10.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.556B | 0.00 |
| Baxter (BAX) | United States | $10.214B | 8.24 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.023B | 28.85 |
| Demant (WILYY) | Denmark | $7.483B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.410B | 13.43 |
| Envista Holdings (NVST) | United States | $3.825B | 21.94 |
| BillionToOne (BLLN) | United States | $3.824B | 0.00 |
| ICU Medical (ICUI) | United States | $3.739B | 23.74 |
| Prestige Consumer Healthcare (PBH) | United States | $3.147B | 14.35 |
| Haemonetics (HAE) | United States | $3.079B | 13.70 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.007B | 0.00 |
| Neogen (NEOG) | United States | $2.230B | 48.81 |
| Perrigo (PRGO) | Ireland | $1.971B | 4.94 |
| LeMaitre Vascular (LMAT) | United States | $1.960B | 39.45 |
| QuidelOrtho (QDEL) | United States | $1.878B | 12.07 |
| AtriCure (ATRC) | United States | $1.831B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.699B | 16.97 |
| Curaleaf Holdings (CURLF) | Canada | $1.472B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.459B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.394B | 61.09 |
| AdaptHealth (AHCO) | United States | $1.368B | 19.80 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.159B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.075B | 319.00 |
| Capricor Therapeutics (CAPR) | United States | $1.056B | 0.00 |
| InMode (INMD) | Israel | $1.051B | 11.87 |
| Tilray Brands (TLRY) | Canada | $0.867B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.862B | 0.00 |
| Omeros (OMER) | United States | $0.831B | 0.00 |
| Valneva SE (VALN) | France | $0.788B | 0.00 |
| CeriBell (CBLL) | United States | $0.750B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.594B | 16.09 |
| Brainsway (BWAY) | Israel | $0.455B | 77.50 |
| Verano Holdings (VRNO) | United States | $0.450B | 0.00 |
| Cerus (CERS) | United States | $0.446B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.372B | 0.00 |
| Evolus (EOLS) | United States | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.304B | 24.24 |
| Quanterix (QTRX) | United States | $0.304B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.255B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.228B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.222B | 130.67 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Organigram Global (OGI) | Canada | $0.204B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.199B | 0.00 |
| High Tide (HITI) | Canada | $0.198B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.198B | 17.75 |
| Sanara MedTech (SMTI) | United States | $0.196B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.188B | 0.00 |
| Accendra Health (ACH) | United States | $0.176B | 1.76 |
| Apyx Medical (APYX) | United States | $0.168B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.154B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.135B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.77 |
| MacroGenics (MGNX) | United States | $0.111B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.109B | 0.00 |
| Biote (BTMD) | United States | $0.104B | 4.54 |
| Exagen (XGN) | United States | $0.087B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 23.50 |
| Sharps Technology (STSS) | United States | $0.049B | 0.00 |
| Nephros (NEPH) | United States | $0.049B | 35.15 |
| Rockwell Medical (RMTI) | United States | $0.045B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.035B | 17.86 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Jin Medical (ZJYL) | China | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Flora Growth (ZSTK) | United States | $0.008B | 0.00 |
| INLIF (INLF) | China | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |